Renaissance Technologies
MIRA icon

Renaissance Technologies’s MIRA Pharmaceuticals MIRA Stock Holding History

Renaissance Technologies’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46,700
Closed -$63.5K – 3555
2025
Q3 		$63.5K Buy
+46,700
New +$67.8K ﹤0.01% 3311
2025
Q1 		– Sell
-45,772
Closed -$52.2K – 3699
2024
Q4 		$52.2K Buy
+45,772
New +$59.8K ﹤0.01% 3383

Other funds holding MIRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Renaissance Technologies's MIRA Position: Q4 2025 in Review

Renaissance Technologies sold out of MIRA Pharmaceuticals (MIRA) in Q4 2025, closing a stake of 46,700 shares — an estimated $63.5K sold.

Renaissance Technologies first reported a position in MIRA in Q4 2024 and held it in 2 quarters. The position peaked at $63.5K in Q3 2025. 25 funds tracked by Wall St. Rank hold MIRA as of Q4 2025.

  • Renaissance Technologies reported no remaining MIRA Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 46,700 MIRA Pharmaceuticals shares in Q4 2025, an estimated $63.5K.
  • Renaissance Technologies first reported a position in MIRA Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Renaissance Technologies's MIRA Pharmaceuticals position peaked at $63.5K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.